Iaterion Pharmaceutical

Iaterion is utilizing a novel discovery made by Dale Leitman, MD, PhD of nuclear receptors reprogramming (NRRP) agents.

Iaterion's team brings decades of experience in the bio-pharmaceutical industry. The team has engaged in all levels of scientific and industrial small molecules and biologics development.

Iaterion's drugs are harnessing its platform for selective nuclear receptor modulators, including NRRPs, receptor subtype selective drugs and tissue specific selective drugs.